Further observations of the effect of furosemide on mesenteric blood flow in dogs.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000037:antagonists & inhibitors; D000818:Animals; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003681:Dehydration / Q000503:physiopathology; D004285:Dogs; D005665:Furosemide / Q000494:pharmacology*; D066298:In Vitro Techniques; D007668:Kidney / Q000502:physiology; D008638:Mesenteric Arteries / Q000187:drug effects*; D008784:Methysergide / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects; D009392:Nephrectomy; D012039:Regional Blood Flow / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012702:Serotonin Antagonists; D014665:Vasodilator Agents / Q000494:pharmacology; D000092502:Renin Inhibitors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000804:Angiotensin II; D002395:Catecholamines; D005665:Furosemide; D008784:Methysergide; D012110:Reserpine; D012702:Serotonin Antagonists; D014665:Vasodilator Agents; D000092502:Renin Inhibitors